At the same time, we found that the expression levels of phosphorylated STAT1 significantly decreased in tumor tissues treated simultaneously with anti-mouse IFN-γ antibody, Efm, and sorafenib compared to the group not treated with anti-mouse IFN-γ antibody (Figure S4). The gene discussed is STAT1; the disease is neoplasm.